From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Fraser Perring of Viceroy threatens defamation proceedings as Home Reit ‘fesses up & considers dodgy sale

By Tom Winnifrith | Thursday 16 February 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It is ouzo time for Fraser Perring of Viceroy and for Boatman Capital. The bears look to be wholly vindicated as Home REIT (HOME) has fessed up to a collapsing business model and has put its rag bag assets up for sale. Indeed it has had one offer but that looks to be related party and shareholders should not expect to get much. This is a scandal and exactly why bear raiders are so needed. Shares in this company were almost 80p when Fraser published his dossier last November. The shares are now suspended at 38p and shareholders will be lucky to get pennies.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:34:35